Medical - Instruments & Supplies
Compare Stocks
2 / 10Stock Comparison
ISRG vs SYK
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
ISRG vs SYK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Instruments & Supplies | Medical - Devices |
| Market Cap | $161.07B | $112.69B |
| Revenue (TTM) | $10.58B | $25.12B |
| Net Income (TTM) | $2.98B | $3.25B |
| Gross Margin | 66.3% | 63.5% |
| Operating Margin | 30.5% | 22.4% |
| Forward P/E | 43.8x | 19.6x |
| Total Debt | $303M | $14.86B |
| Cash & Equiv. | $3.37B | $4.01B |
ISRG vs SYK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Intuitive Surgical,… (ISRG) | 100 | 234.6 | +134.6% |
| Stryker Corporation (SYK) | 100 | 150.3 | +50.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ISRG vs SYK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ISRG carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
- 5.5% 10Y total return vs SYK's 187.1%
- Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
SYK is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 34 yrs, beta 0.55, yield 1.1%
- PEG 1.32 vs ISRG's 2.01
- Beta 0.55, yield 1.1%, current ratio 1.89x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.5% revenue growth vs SYK's 11.2% | |
| Value | Lower P/E (19.6x vs 43.8x), PEG 1.32 vs 2.01 | |
| Quality / Margins | 28.2% margin vs SYK's 12.9% | |
| Stability / Safety | Beta 0.55 vs ISRG's 1.02 | |
| Dividends | 1.1% yield; 34-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -15.4% vs SYK's -22.5% | |
| Efficiency (ROA) | 14.8% ROA vs SYK's 6.9%, ROIC 15.0% vs 11.4% |
ISRG vs SYK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ISRG vs SYK — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ISRG leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SYK is the larger business by revenue, generating $25.1B annually — 2.4x ISRG's $10.6B. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to SYK's 12.9%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $10.6B | $25.1B |
| EBITDAEarnings before interest/tax | $3.8B | $6.3B |
| Net IncomeAfter-tax profit | $3.0B | $3.2B |
| Free Cash FlowCash after capex | $2.8B | $4.3B |
| Gross MarginGross profit ÷ Revenue | +66.3% | +63.5% |
| Operating MarginEBIT ÷ Revenue | +30.5% | +22.4% |
| Net MarginNet income ÷ Revenue | +28.2% | +12.9% |
| FCF MarginFCF ÷ Revenue | +26.8% | +17.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +23.0% | +11.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +18.8% | +56.0% |
Valuation Metrics
SYK leads this category, winning 7 of 7 comparable metrics.
Valuation Metrics
At 35.0x trailing earnings, SYK trades at a 39% valuation discount to ISRG's 57.6x P/E. Adjusting for growth (PEG ratio), SYK offers better value at 2.36x vs ISRG's 2.65x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $161.1B | $112.7B |
| Enterprise ValueMkt cap + debt − cash | $158.0B | $123.5B |
| Trailing P/EPrice ÷ TTM EPS | 57.62x | 35.03x |
| Forward P/EPrice ÷ next-FY EPS est. | 43.84x | 19.62x |
| PEG RatioP/E ÷ EPS growth rate | 2.65x | 2.36x |
| EV / EBITDAEnterprise value multiple | 43.62x | 20.31x |
| Price / SalesMarket cap ÷ Revenue | 16.00x | 4.49x |
| Price / BookPrice ÷ Book value/share | 9.17x | 5.02x |
| Price / FCFMarket cap ÷ FCF | 64.67x | 26.31x |
Profitability & Efficiency
ISRG leads this category, winning 7 of 7 comparable metrics.
Profitability & Efficiency
ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $15 for SYK. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to SYK's 0.66x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +16.9% | +15.0% |
| ROA (TTM)Return on assets | +14.8% | +6.9% |
| ROICReturn on invested capital | +15.0% | +11.4% |
| ROCEReturn on capital employed | +16.5% | +13.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.02x | 0.66x |
| Net DebtTotal debt minus cash | -$3.1B | $10.8B |
| Cash & Equiv.Liquid assets | $3.4B | $4.0B |
| Total DebtShort + long-term debt | $303M | $14.9B |
| Interest CoverageEBIT ÷ Interest expense | — | 6.72x |
Total Returns (Dividends Reinvested)
ISRG leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $12,152 for SYK. Over the past 12 months, ISRG leads with a -15.4% total return vs SYK's -22.5%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs SYK's 1.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -19.3% | -15.2% |
| 1-Year ReturnPast 12 months | -15.4% | -22.5% |
| 3-Year ReturnCumulative with dividends | +49.6% | +5.5% |
| 5-Year ReturnCumulative with dividends | +58.7% | +21.5% |
| 10-Year ReturnCumulative with dividends | +554.2% | +187.1% |
| CAGR (3Y)Annualised 3-year return | +14.4% | +1.8% |
Risk & Volatility
Evenly matched — ISRG and SYK each lead in 1 of 2 comparable metrics.
Risk & Volatility
SYK is the less volatile stock with a 0.55 beta — it tends to amplify market swings less than ISRG's 1.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.02x | 0.55x |
| 52-Week HighHighest price in past year | $603.88 | $404.87 |
| 52-Week LowLowest price in past year | $427.84 | $289.91 |
| % of 52W HighCurrent price vs 52-week peak | +75.1% | +72.7% |
| RSI (14)Momentum oscillator 0–100 | 42.4 | 24.3 |
| Avg Volume (50D)Average daily shares traded | 1.8M | 2.1M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates ISRG as "Buy" and SYK as "Buy". Consensus price targets imply 37.3% upside for ISRG (target: $623) vs 37.2% for SYK (target: $404). SYK is the only dividend payer here at 1.14% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $622.60 | $403.69 |
| # AnalystsCovering analysts | 55 | 50 |
| Dividend YieldAnnual dividend ÷ price | — | +1.1% |
| Dividend StreakConsecutive years of raises | — | 34 |
| Dividend / ShareAnnual DPS | — | $3.36 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.4% | 0.0% |
ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SYK leads in 1 (Valuation Metrics). 1 tied.
ISRG vs SYK: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ISRG or SYK a better buy right now?
For growth investors, Intuitive Surgical, Inc.
(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus 11. 2% for Stryker Corporation (SYK). Stryker Corporation (SYK) offers the better valuation at 35. 0x trailing P/E (19. 6x forward), making it the more compelling value choice. Analysts rate Intuitive Surgical, Inc. (ISRG) a "Buy" — based on 55 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ISRG or SYK?
On trailing P/E, Stryker Corporation (SYK) is the cheapest at 35.
0x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, Stryker Corporation is actually cheaper at 19. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Stryker Corporation wins at 1. 32x versus Intuitive Surgical, Inc. 's 2. 01x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — ISRG or SYK?
Over the past 5 years, Intuitive Surgical, Inc.
(ISRG) delivered a total return of +58. 7%, compared to +21. 5% for Stryker Corporation (SYK). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus SYK's +187. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ISRG or SYK?
By beta (market sensitivity over 5 years), Stryker Corporation (SYK) is the lower-risk stock at 0.
55β versus Intuitive Surgical, Inc. 's 1. 02β — meaning ISRG is approximately 86% more volatile than SYK relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 66% for Stryker Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — ISRG or SYK?
By revenue growth (latest reported year), Intuitive Surgical, Inc.
(ISRG) is pulling ahead at 20. 5% versus 11. 2% for Stryker Corporation (SYK). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to 8. 2% for Stryker Corporation. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ISRG or SYK?
Intuitive Surgical, Inc.
(ISRG) is the more profitable company, earning 28. 4% net margin versus 12. 9% for Stryker Corporation — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus 19. 5% for SYK. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ISRG or SYK more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Stryker Corporation (SYK) is the more undervalued stock at a PEG of 1. 32x versus Intuitive Surgical, Inc. 's 2. 01x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Stryker Corporation (SYK) trades at 19. 6x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 24. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 37. 3% to $622. 60.
08Which pays a better dividend — ISRG or SYK?
In this comparison, SYK (1.
1% yield) pays a dividend. ISRG does not pay a meaningful dividend and should not be held primarily for income.
09Is ISRG or SYK better for a retirement portfolio?
For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
55), 1. 1% yield, +187. 1% 10Y return). Both have compounded well over 10 years (SYK: +187. 1%, ISRG: +554. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ISRG and SYK?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ISRG is a mid-cap high-growth stock; SYK is a mid-cap quality compounder stock. SYK pays a dividend while ISRG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.